Radiopharmacies Now on Dealmakers’ Radar

You can’t get much more “specialty” in the specialty pharmacy business than to deal in radiopharmaceuticals. Two recent deals, announced in August, show this area is heating up. IBA Molecular, a global maker and distributor of radiopharmaceutical products, agreed to pay approximately $613 million for Mallinckrodt‘s (NYSE: MNK) nuclear imaging business, including a portfolio of […]